Average Co-Inventor Count = 8.95
ph-index = 5
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Abbvie Inc. (19 from 822 patents)
2. Abbott Laboratories Corporation (9 from 4,177 patents)
3. Enanta Pharmaceuticals, Inc. (3 from 290 patents)
4. Enata Pharmacueticals, Inc. (1 from 1 patent)
5. Abbvie Bahamas Limited (6 patents)
6. Abbvie Ireland Unlimited Company (0 patent)
28 patents:
1. 10633379 - Bromodomain inhibitors
2. 10131657 - Bromodomain inhibitors
3. 10085985 - Bromodomain inhibitors
4. 10035800 - Substituted 1,4,10-triazadibenzo[cd,f]azulenes, substituted 1,4,5,10-tetraazadibenzo[cd,f]azulenes and substituted 1,4,5,7,10-pentaazadibenzo[cd,f]azulenes as bromodomain inhibitors
5. 9994581 - Bromodomain inhibitors
6. 9957263 - Bromodomain inhibitors
7. 9561231 - Pyridinone and pyridazinone derivatives
8. 9493506 - Macrocyclic hepatitis C serine protease inhibitors
9. 9493411 - Pyrrole-3-carboxamide bromodomain inhibitors
10. 9428514 - Bromodomain inhibitors
11. 9321764 - Dihydro-pyrrolopyridinone inhibitors
12. 9309279 - Macrocyclic hepatitis C serine protease inhibitors
13. 9296741 - Bromodomain inhibitors
14. 9050346 - Bromodomain inhibitors
15. 8951964 - Phenanthridine macrocyclic hepatitis C serine protease inhibitors